UniSA Ventures works with the University of South Australia to maximise the outcomes of intellectual property generated through research.
Universal Biosensors (UBI) is a medical diagnostics company focused on the research, development and manufacture of diagnostic test systems for point-of-care (POC) professional and home use. UBI has partnered with global healthcare company Siemens Healthcare Diagnostics to develop the Xprecia Stride blood coagulation analyser, launched in December 2014, to help patients taking the anticoagulant drug Warfarin manage their medication.
The University of Newcastle is a global leader distinguished by a commitment to equity and excellence. Its research is world-class and diverse as the university's partnerships and collaborations drive innovation.